Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis
2011

Hyaluronidase and its Role in Lung Fibrosis

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Claudia S Bitencourt, Priscilla AT Pereira, Simone G Ramos, Suely V Sampaio, Eliane C Arantes, David M Aronoff, Lúcia H Faccioli

Primary Institution: Universidade de São Paulo

Hypothesis

Can hyaluronidase (HYAL) treatment recruit mesenchymal-like cells to the lung and reduce fibrosis?

Conclusion

Hyaluronidase treatment significantly reduced lung injury and fibrosis while promoting the recruitment of MSC-like cells.

Supporting Evidence

  • Hyaluronidase treatment increased mononuclear cells in the bronchoalveolar fluid.
  • Hyaluronidase reduced collagen deposition in the lungs.
  • Hyaluronidase treatment decreased TGF-β production.
  • MSC-like cells were identified in the bronchoalveolar fluid after treatment.
  • Leukotrienes were involved in the recruitment of cells to the lung.

Takeaway

Hyaluronidase is like a helper that brings special cells to the lungs to fix damage and make them healthier.

Methodology

Mice were treated with intranasal hyaluronidase and assessed for changes in lung cell populations and fibrosis.

Potential Biases

Potential bias in the interpretation of results due to the use of a single animal model.

Limitations

The study primarily used a mouse model, which may not fully replicate human responses.

Participant Demographics

C57BL6/6 mice, 18-25 g.

Statistical Information

P-Value

0.0024

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1755-1536-4-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication